Vanderbilt Institute for Clinical and Translational Research (VICTR) Archive — Page 4 of 7
-
January 2, 2020
Chris Pua’s behind-the-scenes work brings him into spotlight
He hopes the software applications and systems he and his team develop work so well that users don’t even notice them. -
December 12, 2019
A new anti-seizure target?
Vanderbilt neurologists have identified a protein modification that could be targeted to reduce neuronal excitability in epilepsy. -
October 3, 2019
Study: personalized decision support affects intensive care
For patients in pediatric intensive care who are at high risk for acute kidney injury (AKI), giving clinicians automated decision support during the electronic order entry process increased the rate of blood testing for AKI by 9%. -
October 2, 2019
Research team sorts out drug screen false positive results
Vanderbilt investigators have identified 13 previously unknown drug compounds that cause false positive screenings for amphetamines, buprenorphine (an opioid), cannabinoids and methadone. -
September 10, 2019
Relational memory in early psychosis
Studies of relational memory function may reveal novel mechanisms for therapeutic intervention for patients in the early stages of psychosis. -
August 15, 2019
REDCap data management tool reaches million user mark
Fifteen years after it was launched, REDCap, Vanderbilt University’s research data management tool, has reached 1 million users throughout the world. -
July 11, 2019
Working memory in psychotic disorders
Functional MRI studies have revealed that targeting activation of certain brain regions may improve working memory and cognition in psychotic disorders.